V2 Financial group’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
V2 Financial group's IHE Position: Q3 2026 in Review
V2 Financial group held its iShares US Pharmaceuticals ETF (IHE) position steady in Q3 2026 at 3,300 shares worth $332K. The position accounts for 0.11% of the portfolio, ranked #96.
V2 Financial group first reported a position in IHE in Q2 2021 and has held it in 18 quarters since. 228 funds tracked by Wall St. Rank hold IHE as of Q3 2026.
- V2 Financial group held 3,300 shares of iShares US Pharmaceuticals ETF worth $332K as of Q3 2026.
- V2 Financial group left its iShares US Pharmaceuticals ETF share count unchanged in Q3 2026.
- iShares US Pharmaceuticals ETF made up 0.11% of V2 Financial group's portfolio in Q3 2026, its #96 holding.
- V2 Financial group first reported a position in iShares US Pharmaceuticals ETF in Q2 2021 and has held it in 18 quarters since.
- 228 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.
Based on V2 Financial group's 13F filing for Q3 2026, filed 13 Nov 2026.